---
document_datetime: 2025-10-21 12:25:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/idacio-epar-all-authorised-presentations_en.pdf
document_name: idacio-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9528971
conversion_datetime: 2025-12-20 08:43:25.741416
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                          | Content (concentration)   | Pack size                              |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------------------------|---------------------------|----------------------------------------|
| EU/1/19/1356/002 | Idacio            | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                   | 0.8 ml (40 mg/0.8ml)      | 2 pre-filled syringes + 2 alcohol pads |
| EU/1/19/1356/003 | Idacio            | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre-filled pen | 0.8 ml (40 mg/0.8ml)      | 2 pre-filled pens + 2 alcohol pads     |
| EU/1/19/1356/004 | Idacio            | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                   | 0.8 ml (40 mg/0.8ml)      | 6 pre-filled syringes + 6 alcohol pads |
| EU/1/19/1356/005 | Idacio            | 40 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre-filled pen | 0.8 ml (40 mg/0.8ml)      | 6 pre-filled pens + 6 alcohol pads     |